Calcium channel blockers and clinical outcomes in patients with continuous-flow left ventricular assist devices

被引:0
作者
Tie, Hongtao [1 ,2 ]
Li, Zhenhan [3 ,4 ]
Welp, Henryk [1 ]
Guha, Avirup [5 ,6 ]
Caraballo, Cesar [7 ,8 ]
Deschka, Heinz [1 ]
Shi, Rui [9 ]
Zheng, Xiaoqing [10 ]
Martens, Sven [1 ]
Sindermann, Jurgen [1 ]
Chen, Dan [2 ]
Wu, Qingchen [2 ]
Martens, Sabrina [1 ]
机构
[1] Univ Hosp Muenster, Dept Cardiothorac Surg, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Chongqing, Peoples R China
[3] Chongqing Tradit Chinese Med Hosp, Dept Endocrinol, Chongqing, Peoples R China
[4] Univ Hosp Muenster, Dept Anaesthesiol Intens Care Med & Pain Med, Munster, Germany
[5] Augusta Univ, Med Coll Georgia, Dept Internal Med, Div Cardiol, Augusta, GA USA
[6] Ohio State Univ, Med Ctr, Cardiooncol Program, Div Cardiol, Columbus, OH USA
[7] Yale Sch Med, Sect Cardiovasc Med, New Haven, CT USA
[8] Ctr Outcomes Res & Evaluat, New Haven, CT USA
[9] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Crit Care Med, Guangzhou, Peoples R China
[10] Univ Pittsburgh, Pittsburgh, PA USA
关键词
Calcium channel blocker; LVAD; Survival; Adverse events; WORSENING RENAL-FUNCTION; CHRONIC HEART-FAILURE; EJECTION FRACTION; TRANSPLANTATION; ASSOCIATION; AMLODIPINE; SOCIETY; RISK;
D O I
10.1002/ehf2.14576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsCurrent guidelines suggest calcium channel blockers (CCBs) as the second or third option for blood pressure management in patients with left ventricular assist device (LVAD). However, the clinical outcomes of patients with LVAD who receive CCBs remain unclear. Our study aims to analyse the association of CCBs with clinical outcomes in patients after LVAD implantation.Methods and resultsThis is a retrospective analysis based on the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) from 2006 to 2017, and adult patients who were alive with LVAD and CCB treatment information at 6 months after implantation were included. Among 10 717 patients, 1369 received CCBs 6 months after implantation, and there was an increasing trend of CCB use after LVAD. Patients receiving CCB therapy at 6 months had a similar 5 year survival rate to those not receiving CCB [49.6%, 95% confidence interval (CI): 47.5-51.7% vs. 51.1%, 95% CI: 45.3-56.7%]. In both Cox and competing risk regressions after adjusting for confounding factors, CCB treatment at 6 months after implantation was not associated with long-term mortality [hazard ratio (HR): 1.03, 95% CI: 0.91-1.17, P = 0.624 and subdistribution HR (SHR): 1.07, 95% CI: 0.95-1.22, P = 0.260]. Consistently, in time-varying models, CCB treatment was not linked to long-term mortality (HR: 0.97, 95% CI: 0.87-1.09, P = 0.682 and SHR: 1.05, 95% CI: 0.94-1.18, P = 0.359). This null association remained in subgroup analysis according to device strategy and propensity-matching analyses. Neurological dysfunction, stroke, bleeding, rehospitalization, and renal dysfunction were more likely to occur among those with CCB when compared with those without CCB treatment.ConclusionsIn patients with LVAD, CCB therapy fails to show benefits in long-term survival and is associated with increased incidences of neurological dysfunction, bleeding, renal dysfunction, and rehospitalization.
引用
收藏
页码:271 / 281
页数:11
相关论文
共 50 条
[41]   Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding [J].
Axelrad, Jordan E. ;
Pinsino, Alberto ;
Trinh, Pauline N. ;
Thanataveerat, Anusorn ;
Brooks, Christian ;
Demmer, Ryan T. ;
Effner, Lisa ;
Parkis, Grant ;
Cagliostro, Barbara ;
Han, Jiho ;
Garan, A. Reshad ;
Topkara, Veli ;
Takeda, Koji ;
Takayama, Hiroo ;
Naka, Yoshifumi ;
Ramirez, Ivonne ;
Garcia-Carrasquillo, Reuben ;
Colombo, Paolo C. ;
Gonda, Tamas ;
Yuzefpolskaya, Melana .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (06) :723-732
[42]   Risk Factors for Early Death in Patients Bridged to Transplant With Continuous-Flow Left Ventricular Assist Devices [J].
Arnaoutakis, George J. ;
George, Timothy J. ;
Kilic, Arman ;
Beaty, Claude A. ;
Weiss, Eric S. ;
Conte, John V. ;
Shah, Ashish S. .
ANNALS OF THORACIC SURGERY, 2012, 93 (05) :1549-1555
[43]   Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices [J].
Loyaga-Rendon R.Y. ;
Jani M. ;
Fermin D. ;
McDermott J.K. ;
Vancamp D. ;
Lee S. .
Current Heart Failure Reports, 2017, 14 (6) :465-477
[44]   Clinical Significance of Early Hospital Readmission in Continuous-Flow Left Ventricular Assist Device Patients [J].
Kutyifa, Valentina ;
Naqvi, Syed Y. ;
Vidula, Himabindu ;
Thomas, Sabu ;
Sherazi, Saadia ;
McNitt, Scott ;
Alexis, Jeffrey D. .
ASAIO JOURNAL, 2020, 66 (07) :760-765
[45]   Noninvasive Blood Pressure Monitor Designed for Patients With Heart Failure Supported with Continuous-Flow Left Ventricular Assist Devices [J].
Sajgalik, Pavol ;
Kremen, Vaclav ;
Fabian, Vratislav ;
Maltais, Simon ;
Stulak, John M. ;
Kushwaha, Sudhir S. ;
Joyce, Lyle D. ;
Schirger, John A. ;
Johnson, Bruce D. .
ASAIO JOURNAL, 2019, 65 (02) :127-133
[46]   Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices [J].
Fried, Justin ;
Levin, Allison P. ;
Mody, Kanika M. ;
Garan, Arthur R. ;
Yuzefpolsakaya, Melana ;
Takayama, Hiroo ;
Diuguid, David L. ;
Naka, Yoshifumi ;
Jorde, Ulrich ;
Uriel, Nir .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (11) :1119-1125
[47]   INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices Risk Factors and Outcomes [J].
Acharya, Deepak ;
Loyaga-Rendon, Renzo ;
Morgan, Charity J. ;
Sands, Kara A. ;
Pamboukian, Salpy V. ;
Rajapreyar, Indranee ;
Holman, William L. ;
Kirklin, James K. ;
Tallaj, Jose A. .
JACC-HEART FAILURE, 2017, 5 (10) :703-711
[48]   Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices [J].
Sparrow, Christopher T. ;
Nassif, Michael E. ;
Raymer, David S. ;
Novak, Eric ;
LaRue, Shane J. ;
Schilling, Joel D. .
JACC-HEART FAILURE, 2015, 3 (12) :956-964
[49]   Changes in Renal Function After Implantation of Continuous-Flow Left Ventricular Assist Devices [J].
Hasin, Tal ;
Topilsky, Yan ;
Schirger, John A. ;
Li, Zhuo ;
Zhao, Yanjun ;
Boilson, Barry A. ;
Clavell, Alfredo L. ;
Rodeheffer, Richard J. ;
Frantz, Robert P. ;
Edwards, Brooks S. ;
Pereira, Naveen L. ;
Joyce, Lyle ;
Daly, Richard ;
Park, Soon J. ;
Kushwaha, Sudhir S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (01) :26-36
[50]   Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle [J].
Kawabori, Masashi ;
Kurihara, Chitaru ;
Sugiura, Tadahisa ;
Cohn, William E. ;
Civitello, Andrew B. ;
Frazier, O. Howard ;
Morgan, Jeffrey A. .
ANNALS OF THORACIC SURGERY, 2018, 105 (03) :799-806